美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

CAR-T

1,728.00

-5.9070-0.34%

漲家數：1

跌家數：1

平家數：- -

市盈率：- -

高：1,732.01

開：1,732.01

低：1,705.45

收：1,733.91

成交量：265.68萬

成交額：3.76億

市值：4,453.69億

流通市值：4,370.97億

資料載入中...

總覽新聞資訊

吉利德科學攜手巴西衞生部，共促Lenacapavir本地化生產新篇章

吉利德科學：持續探索與泛美衞生組織合作，助力各國準備好並擴大長效艾滋病預防措施的普及

吉利德科學攜手泛美衞生組織，加速拉美及加勒比地區HIV預防藥物Lenacapavir的可及性

吉利德高管表示，未來幾個季度HIV市場增長或將回歸2%-3%常態水平

吉利德高管透露：周服HIV預防藥物有望2027年第一季度上市

諾華前中國總裁張穎加盟傳奇生物，擔任首席執行官

諾華接連兩次III期失敗的啓示

第七批國家組織醫用耗材集中採購開標；諾華大股東呼籲改組董事會｜醫藥早參

每日经济新闻

美股盤前｜庫珀醫療績後跌超17%，美鷹服飾跌14%；白宮的銅關税計劃陷入停滯；美債30年期收益率創2007年來新高

老虎资讯综合

諾華製藥(NVS.US)大股東呼籲改組董事會，以改善公司治理。此前該公司股價因連續試驗受挫於本周創下紀錄跌幅。大股東Da

Artisan Partners：在藥物試驗接連受挫後諾華應在董事會層面進行改組

滙豐：將諾華製藥的評級上調至「持有」，目標價110瑞士法郎。

心血管新藥研發遇困局：諾華重磅臨床折戟 Lp（a）指標降了但心血管疾病風險沒降

每日经济新闻

我武生物董事長因個人原因辭職；諾華新藥III期臨床未達主要終點 | 醫藥早參

每日经济新闻

Assembly Biosciences有望獲得高達2.8億美元里程碑付款及美國境外特許權使用費

Assembly Biosciences旗下Gs-1179預計2026年底前將推進至生殖器皰疹二期臨床試驗階段

Assembly Biosciences：吉利德獨享HSV HPI項目臨床開發與商業化權利

Assembly Biosciences行使與吉利德關於HSV解旋酶-引物酶抑制劑項目的美國利潤分成選擇權

吉利德科學(GILD)股票9月8日盤中下跌3.26%：釋放什麼信號？

TradingKey中文

美股異動｜諾華製藥重挫超13%創1月以來新低，三項臨床項目接連受挫

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hant/stock/BK4578/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4578","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4578\",,,,,undefined,":{"symbol":"BK4578","market":"US","secType":"PLATE","nameCN":"CAR-T","latestPrice":1728.0023,"timestamp":1789489160189,"preClose":1733.9093,"halted":0,"volume":2656790,"delay":0,"changeRate":-0.003407,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":-5.906982,"latestTime":"09-15 12:19:21 EDT","open":1732.0104,"high":1732.0104,"low":1705.446,"amount":376399632.287701,"amplitude":0.01532,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1789502400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":8.300443,"peRate":46.548588,"turnoverRate":0.00086,"increases":0,"decrements":2,"flats":0,"marketCap":445368942592,"floatMarketCap":437096972288},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4578\",,,,,undefined,":{"symbol":"BK4578","high":1732.0104,"amplitude":0.01532,"preClose":1733.9093,"low":1705.446,"pbRate":"8.300443","latestPrice":1728.0023,"volume":2656790,"delay":0,"open":1732.0104,"prevYearClose":1612.5378,"prevWeekClose":1707.2908,"prevMonthClose":1830.2803,"prevQuarterClose":1768.1697,"fiveDayClose":1725.5667,"twentyDayClose":1794.044,"sixtyDayClose":1684.6451,"secType":"PLATE","market":"US","turnoverRate":0.00086,"peRate":46.548588,"marketCap":445368942592,"floatMarketCap":437096972288,"timestamp":1789489160189,"nameCN":"CAR-T"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4578\",,,,undefined,":{"bkCode":"BK4578","up":1,"down":1,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4578\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1120765496","title":"吉利德科學攜手巴西衞生部，共促Lenacapavir本地化生產新篇章","url":"https://stock-news.laohu8.com/highlight/detail?id=1120765496","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120765496?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 23:15","pubTimestamp":1789485331,"startTime":"0","endTime":"0","summary":"吉利德科学公司近日透露，正积极与巴西卫生部探索合作良机，旨在助力该国实现Lenacapavir药物的本土生产愿景。这一举措，无疑为巴西医药产业自主化进程注入了强劲动力。据悉，双方的洽谈聚焦于如何深化协作，以切实推进巴西卫生部既定的战略目标——即构建并强化Lenacapavir的本地制造能力。Lenacapavir，作为一款备受瞩目的长效抗逆转录病毒药物，其本地化生产若能落地，对巴西乃至更广泛地区的HIV防治工作意义深远。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBB","LU0114720955.EUR","IE00BSNM7G36.USD","BK4139","BK4583","LU1023059063.AUD","LU0289739699.SGD","LU0965509283.SGD","LU1066051498.USD","LU1778281490.HKD","LU0859254822.USD","LU1430594728.SGD","MEDI","LU0320765992.SGD","LU0965509101.SGD","LU2357627491.SGD","SG9999015986.USD","IE00B19Z3581.USD","IE00B3T34201.USD","LU2089984988.USD","BBH","LU2468319806.SGD","GILD","BK4568","LU0122379950.USD","SG9999015945.SGD","IE00B19Z3B42.SGD","LU1057294990.SGD","BK4585","BK4588","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","LU1674673428.USD","LU1934455277.USD","LU1585245621.USD","LU0109394709.USD","BK4550","LU0058720904.USD","LU0882574055.USD","LU1934455863.HKD","TMED","LU1061106388.HKD","LU1934455194.USD","LU0965508806.USD","TBXU","LU1674673691.USD","BK4566","LU1066053197.SGD","LU1037948897.HKD","LU0234570918.USD","LU0965509010.AUD","LU0823416689.USD","LU1037948541.HKD","IBBQ","BIB","LU0889565916.HKD","LU1839511570.USD","SG9999015952.SGD","BK4532","BMED","IE00B7SZLL34.SGD","LU0861579265.USD","SG9999015978.USD","LU2087621335.USD","BK4578","IE0002270589.USD","LU2112291526.USD","LU2324357040.USD","LU1571399168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158863992","title":"吉利德科學：持續探索與泛美衞生組織合作，助力各國準備好並擴大長效艾滋病預防措施的普及","url":"https://stock-news.laohu8.com/highlight/detail?id=1158863992","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158863992?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 23:15","pubTimestamp":1789485330,"startTime":"0","endTime":"0","summary":"吉利德科学（Gilead Sciences）宣布，将继续探索与泛美卫生组织（PAHO）的合作机会，以支持各国做好充分准备，并推动长效艾滋病预防手段的可及性扩展。这一举措旨在强化全球公共卫生应对体系，尤其是针对中低收入国家的需求，通过技术转移、能力建设及供应链优化等途径，加快长效预防方案的落地与规模化应用。双方的合作重点在于应对实施层面的挑战，确保相关资源能够高效、公平地分配至最需要的人群，从而在更大范围内遏制HIV的传播。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1778281490.HKD","BK4550","LU0823416689.USD","IE00B3T34201.USD","LU1430594728.SGD","SG9999015945.SGD","BBH","BK4139","BK4588","LU0109394709.USD","LU0320765992.SGD","LU1571399168.USD","IBBQ","LU0965509283.SGD","LU1585245621.USD","MEDI","LU2089984988.USD","BK4578","SG9999015986.USD","LU1066051498.USD","LU1839511570.USD","BK4583","LU0122379950.USD","LU2324357040.USD","LU1674673428.USD","SG9999015978.USD","LU0859254822.USD","LU0882574055.USD","LU0965509010.AUD","LU1057294990.SGD","LU1061106388.HKD","LU2468319806.SGD","LU2112291526.USD","BK4532","LU0965509101.SGD","BMED","LU1934455194.USD","LU1037948541.HKD","LU2357627491.SGD","IBB","LU1674673691.USD","BK4585","TBXU","LU0861579265.USD","LU0234570918.USD","IE00B7SZLL34.SGD","LU0114720955.EUR","LU1037948897.HKD","LU1934455277.USD","BK4568","LU0889565916.HKD","IE00BKVL7J92.USD","LU1066053197.SGD","LU2087621335.USD","LU1934455863.HKD","SG9999015952.SGD","IE00B19Z3B42.SGD","LU1023059063.AUD","BIB","IE0002270589.USD","IE00BZ1G4Q59.USD","LU0289739699.SGD","TMED","LU0058720904.USD","IE00BSNM7G36.USD","GILD","BK4566","LU0965508806.USD","IE00B19Z3581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159280995","title":"吉利德科學攜手泛美衞生組織，加速拉美及加勒比地區HIV預防藥物Lenacapavir的可及性","url":"https://stock-news.laohu8.com/highlight/detail?id=1159280995","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159280995?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 23:10","pubTimestamp":1789485009,"startTime":"0","endTime":"0","summary":"吉利德科学（Gilead Sciences）日前宣布，与泛美卫生组织（PAHO）达成一项战略合作。此番联手，旨在显著提升一年两针的HIV预防药物Lenacapavir在拉丁美洲及加勒比地区的可及性。双方的合作，将为该区域的高风险人群带来更便捷的预防选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","LU2324357040.USD","LU0114720955.EUR","MEDI","SG9999015978.USD","LU1430594728.SGD","BIB","IE00B19Z3581.USD","LU1839511570.USD","GILD","LU2089984988.USD","LU1037948541.HKD","LU0965509101.SGD","LU0289739699.SGD","LU2112291526.USD","BK4566","IE00B7SZLL34.SGD","IE00BZ1G4Q59.USD","IBBQ","LU1037948897.HKD","BK4578","SG9999015986.USD","LU0965508806.USD","LU2468319806.SGD","LU2087621335.USD","LU2357627491.SGD","BK4139","LU1023059063.AUD","LU0320765992.SGD","LU0882574055.USD","LU1934455277.USD","LU0861579265.USD","IE00BSNM7G36.USD","LU1585245621.USD","LU0122379950.USD","LU0234570918.USD","LU1778281490.HKD","BK4568","LU0889565916.HKD","LU0058720904.USD","LU1674673691.USD","BK4550","LU1061106388.HKD","LU1571399168.USD","BMED","LU1066053197.SGD","IE00B3T34201.USD","IE0002270589.USD","BBH","IE00BKVL7J92.USD","LU1934455863.HKD","BK4585","TBXU","TMED","IE00B19Z3B42.SGD","LU0965509283.SGD","LU0109394709.USD","LU0823416689.USD","LU1057294990.SGD","LU0859254822.USD","SG9999015945.SGD","BK4588","LU1674673428.USD","LU1934455194.USD","IBB","BK4532","LU0965509010.AUD","SG9999015952.SGD","LU1066051498.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153389014","title":"吉利德高管表示，未來幾個季度HIV市場增長或將回歸2%-3%常態水平","url":"https://stock-news.laohu8.com/highlight/detail?id=1153389014","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153389014?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 23:09","pubTimestamp":1789484948,"startTime":"0","endTime":"0","summary":"吉利德高管在电话会议中透露，该公司预计HIV治疗市场的增长势头将在未来几个季度内逐步趋于稳定，最终回到2%至3%的年增长区间。这一表态正值市场对HIV药物需求持续波动的关键节点。高管指出，当前的增长水平仍高于长期趋势，但随着时间推移，这种偏热的状态将逐渐降温。整个行业的扩张速度，预计将在近期内回落至更为可持续的轨道上。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0859254822.USD","LU0965509283.SGD","IE00B19Z3B42.SGD","IBB","IE00B19Z3581.USD","LU0965509101.SGD","BBH","BK4585","LU1778281490.HKD","BIB","LU1037948897.HKD","SG9999015945.SGD","BK4583","IE00BZ1G4Q59.USD","LU1037948541.HKD","LU1430594728.SGD","IE00BKVL7J92.USD","IE00BSNM7G36.USD","LU1674673428.USD","TBXU","LU2324357040.USD","LU1839511570.USD","LU1934455277.USD","BK4139","BK4568","LU1023059063.AUD","SG9999015986.USD","LU0234570918.USD","BK4588","IE00B3T34201.USD","BK4578","LU1934455194.USD","MEDI","LU2112291526.USD","SG9999015978.USD","SG9999015952.SGD","BMED","LU0122379950.USD","LU0109394709.USD","LU1061106388.HKD","LU1066051498.USD","LU0058720904.USD","LU0861579265.USD","LU2089984988.USD","LU0965508806.USD","TMED","LU1585245621.USD","GILD","IE0002270589.USD","LU0882574055.USD","LU0289739699.SGD","LU0114720955.EUR","BK4532","IE00B7SZLL34.SGD","BK4566","LU2087621335.USD","LU0965509010.AUD","LU1674673691.USD","LU1066053197.SGD","LU0320765992.SGD","LU0889565916.HKD","LU1934455863.HKD","LU0823416689.USD","LU1057294990.SGD","LU2468319806.SGD","LU2357627491.SGD","BK4550","LU1571399168.USD","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131138631","title":"吉利德高管透露：周服HIV預防藥物有望2027年第一季度上市","url":"https://stock-news.laohu8.com/highlight/detail?id=1131138631","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131138631?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 23:05","pubTimestamp":1789484737,"startTime":"0","endTime":"0","summary":"吉利德科学高管在电话会议中表示，其每周口服HIV预防药物预计将于2027年第一季度正式推出。这一表态为公司抗艾药物管线注入了新的期待。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GILD","LU0058720904.USD","BK4139","BIB","LU0965509283.SGD","TBXU","LU2324357040.USD","BK4550","IE00BSNM7G36.USD","LU0114720955.EUR","LU0234570918.USD","LU0289739699.SGD","LU1571399168.USD","IE00B7SZLL34.SGD","LU1066051498.USD","LU1037948541.HKD","LU0122379950.USD","LU1430594728.SGD","SG9999015986.USD","LU1061106388.HKD","LU0965508806.USD","LU2357627491.SGD","BK4578","BK4566","IE00B19Z3B42.SGD","LU0109394709.USD","LU1585245621.USD","SG9999015978.USD","BBH","LU1674673691.USD","LU1023059063.AUD","LU1066053197.SGD","LU0889565916.HKD","LU1934455277.USD","IE00BKVL7J92.USD","LU2089984988.USD","BK4532","BK4568","LU0320765992.SGD","LU1057294990.SGD","LU0861579265.USD","LU1934455194.USD","IE00B3T34201.USD","LU0823416689.USD","IBB","LU1674673428.USD","LU1934455863.HKD","BK4588","IE00B19Z3581.USD","LU2087621335.USD","LU2112291526.USD","LU2468319806.SGD","SG9999015952.SGD","BMED","IE0002270589.USD","LU1037948897.HKD","IBBQ","LU0882574055.USD","LU0965509010.AUD","SG9999015945.SGD","TMED","BK4585","BK4583","LU1839511570.USD","MEDI","LU1778281490.HKD","IE00BZ1G4Q59.USD","LU0965509101.SGD","LU0859254822.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667822647","title":"諾華前中國總裁張穎加盟傳奇生物，擔任首席執行官","url":"https://stock-news.laohu8.com/highlight/detail?id=2667822647","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667822647?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 20:43","pubTimestamp":1789476228,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","CANC","MEMS","MEDI","IE00B4R5TH58.HKD","LU0208291251.USD","LU0211331839.USD","PPH","BK4139","BK4588","IE0009355771.USD","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","LU0320765489.SGD","BK4505","NVS","BK4007","IE00B2B36J28.USD","LEGN","IE0002141913.USD","MEDX","LU0070302665.USD","BK4578","IE00BFTCPJ56.SGD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667611645","title":"諾華接連兩次III期失敗的啓示","url":"https://stock-news.laohu8.com/highlight/detail?id=2667611645","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667611645?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 14:28","pubTimestamp":1789453731,"startTime":"0","endTime":"0","summary":"先是Pelacarsen，诺华重金押注的Lp靶向药，在全球III期研究LpHORIZON中，未能显著降低患者的主要心血管事件风险。紧接着，全球首个抗体寡核苷酸偶联药物del-desiran，也在III期HARBOR研究中错失主要终点。短短几天，两次III期失败。两条路，代价都极其高昂，且都押注在一个刚刚被III期失败动摇过的生物学假设上。Pelacarsen的III期试验耗资数以亿计，8,323名患者付出了宝贵的时间与信任。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1788926737124467348","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["IE0009355771.USD","BK4588","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","BK4532","IE00BFTCPJ56.SGD","LU0320765489.SGD","MEDX","IE0002141913.USD","IE00BJT1NW94.SGD","PPH","LU0070302665.USD","BK4007","NVS","BK4585","LU0211331839.USD","LU0208291251.USD","BK4578","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666519701","title":"第七批國家組織醫用耗材集中採購開標；諾華大股東呼籲改組董事會｜醫藥早參","url":"https://stock-news.laohu8.com/highlight/detail?id=2666519701","media":"每日经济新闻","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666519701?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 07:01","pubTimestamp":1789081313,"startTime":"0","endTime":"0","summary":"丨2026年9月11日星期五丨NO.1爱康医疗宣布提高股东股息分派占归母净利比例9月10日，爱康医疗基于对集团未来业绩及长期发展前景的信心，宣布股东股息分派及回报计划，截至2026年12月31日止财政年度，年度股息派付比例提高至不低于归母净利润的55%；截至2027年12月31日及2028年12月31日止财政年度各年，派息比例提升至不低于归母净利润的60%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609113871018788.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609113871018788.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1574","PPH","09939","IE0009355771.USD","MEDX","BK4588","BK1515","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","LU0320765489.SGD","BK4578","IE00BJT1NW94.SGD","NVS","LU0208291251.USD","BK4585","BK4532","IE0002141913.USD","BK4007","LU0211331839.USD","LU0070302665.USD","BK1161","159938","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140105110","title":"美股盤前｜庫珀醫療績後跌超17%，美鷹服飾跌14%；白宮的銅關税計劃陷入停滯；美債30年期收益率創2007年來新高","url":"https://stock-news.laohu8.com/highlight/detail?id=1140105110","media":"老虎资讯综合","labels":["AIColumn"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140105110?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 20:00","pubTimestamp":1789041651,"startTime":"0","endTime":"0","summary":"01 股市截至9月10日，美股三大期指涨跌互现。其仍保留2027年Palantir与纳指100 ETF长周期看跌合约，并进一步压缩其他头寸以降低风险暴露。该系列产品计划追踪热门美股及ETF的小时级收益倍数，为短线交易者提供新的杠杆工具。野村指出地缘政治、利率与通胀形成“负面风险三角”，推动看涨偏斜升至历史高位，市场或迎来更高波动。","market":"sg","thumbnail":"https://static.tigerbbs.com/ed4ee39e6b0f45214393093d70ba81a8","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/ed4ee39e6b0f45214393093d70ba81a8"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"AIColumn","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CGIC","LU1852331112.SGD","LU2461242641.AUD","GMET","LU1720051108.HKD","LU1992135399.USD","IE0034235295.USD","SG9999002232.USD","LU1066051811.HKD","LU2357627491.SGD","LU2462157665.USD","IE00B3T34201.USD","LU0330918003.SGD","LU0158827781.USD","BK4609","LU0050427557.USD","LU1145028129.USD","LU1934455277.USD","BK4581","LU2106854487.HKD","SGXZ23171101.USD","LU1721428933.USD","LU0384037296.USD","LU1883866441.USD","LU0889566641.SGD","LU2041044095.USD","LU0553294199.USD","LU2148611432.USD","SG9999002224.SGD","LEGR","LU0094547139.USD","LU1988902786.USD","SMHX","LU2125909247.SGD","LU0354030438.USD","LU0572940350.SGD","LU2458330243.SGD","LU2360032135.SGD",".DJI","IE00B5949003.HKD","IE00BJJMRY28.SGD","LU0476273544.USD","LU2168564065.EUR","BK4094","LU1923623000.USD","FXL","BK4608","CHPS","IE0003U64NQ7.SGD","BK4504","LU2089283258.USD","LU0072462343.USD","LU2746668974.SGD","LU2092937148.SGD","LU1691799644.USD","GAMR","LU2237438978.USD","LU0082616367.USD","LU0127658192.USD","LU1868838027.USD","IE00BD6J9T35.USD","LU0823414478.USD","LU1282649810.SGD","EMSF","LU2452424414.USD","LU0943347566.SGD","PSI","LU2361044865.SGD","WLDR","BK4116","ASIA","BAI","LU1366334651.USD","IE0004445015.USD","IE000ITXATA3.USD","IE00BMPRXR70.SGD","IE00B19Z8X17.USD","LU0683600562.USD","LU2023250504.SGD","LU1548497426.USD","SG9999015952.SGD","LU0950373646.USD","LU1116320901.HKD","LU0965509010.AUD","LU2108987350.USD","LU2463028550.USD","LU2433249047.HKD","LU2931357623.SGD","LU0823411888.USD","EMET","LU0345769128.USD","LU0726765562.USD","BK4605","LU0278409577.USD","EMM","LU2168564495.EUR","PICK","SG9999015986.USD","LU1551013342.USD","BK4532","LU1202635105.USD","LU2322448957.HKD","IE00B19Z9Z06.USD","LU0096364046.USD","LU1242518931.SGD","LU2065169927.USD","LU2237443382.USD","LU1935042215.USD","LU0274383776.USD","SDOW","VT","LU0256863902.USD","DDM","IE00B894F039.SGD","SG9999018857.SGD","IE00BMPRXN33.USD","LU2298321311.HKD","LU0308772762.SGD","LU1400636657.SGD","LU1645745479.HKD","BK4220","LU0444971666.USD","LU1280957306.USD","LU2357125470.USD","LU0289739343.SGD","LU2089284900.SGD","COPP","LU1803068979.SGD","SG9999001424.SGD","LU2552382132.HKD","LU1633808545.USD","LU0472753341.HKD","LU2360106780.USD","LU0859254822.USD","LU1037948541.HKD","LU0203202063.USD","LU2065171311.SGD","LU1242518857.USD","LU2111349929.HKD","LU0957808578.USD","LU1153585028.USD","LU1923622291.USD","LU1791710582.SGD","CWI","LU1914381329.SGD","LU2065171402.SGD","IE00B7SZLL34.SGD","LU0128525929.USD","LU1935043536.SGD","LU1989772923.USD","LU2458330169.SGD","HK0000306701.USD","LU0265550946.USD","LU2077746001.SGD","LU2272731865.HKD","HK0000306685.HKD","ILDR","LU1878469433.USD","HK0000320264.USD","LU0823421416.USD","LU0642271901.SGD","LU1880398471.USD","SG9999018865.SGD","LU0353189763.USD","BK7016","LU0868494617.USD","LU2023251221.USD","LU2213496289.HKD","LU0823434740.USD","EMC","LU0792757196.USD","LU0345781412.USD","LU0266512127.USD","LU0965508806.USD","SG9999014906.USD","LU2552382058.USD","IE0002270589.USD","LU1366333091.USD","LU1934455194.USD","BK7095","LU0541501648.USD","LU2487616109.SGD","LU0061474705.USD","LU0466842654.USD","ESLG","LU2491050071.SGD","LU1868836757.USD","IE00B19Z9P08.USD","LU0757428866.USD","LU2290526834.HKD","COPX","SOXX","LU2498475776.HKD","BK4567","LU0541502299.USD","AIFD","LU2125909593.SGD","IE00BKPKM429.USD","IE00BZ199S13.USD","IE00BQXX3F31.USD","LU2211814178.USD","LU0072463663.USD","LU0882747503.HKD","IE00B19Z9505.USD","LU0861579265.USD","LU2294711713.HKD","BK4587","LU1861215975.USD","COPA","IE00BMPRXQ63.HKD","AIQ","BK4533","LU0211331839.USD","ARTY","LU0323591593.USD","LU2471134796.USD","LU2750360997.AUD","LU0289961442.SGD","LU2602419157.SGD","SG9999015341.SGD","LU0238689110.USD","LU0053666078.USD","LU1674673691.USD","IE00BZ9MQY76.HKD","LU2381873111.SGD","LU2543165471.USD","LU0557290698.USD","IE000W1ABFV2.USD","DISK","CGDG","IE00B4R5TH58.HKD","LU2357305700.SGD","LU1048588211.SGD","METV","SG9999014559.SGD","LU0106261372.USD","SETM","LU2168564149.EUR","LU2462611646.USD","NBDS","LU0107464264.USD","LU1035773651.USD","LU2092937221.SGD","LU0097036916.USD","LU2322448791.USD","LU0566484027.USD","SHOC","TYLG","IE00B1BXHZ80.USD","BREW","FTEC","IE0009355771.USD","LU0786609619.USD","LU1551013425.SGD","BK4612","LU2237443895.HKD","LU0056508442.USD","LU1674673428.USD","HK0000304805.HKD","LU2491050154.USD","LU1144417596.USD","CLSE","LU0266013472.USD","BK4602","LU1720051017.SGD","LU0175139822.USD","LU0788109477.HKD","LU0823414551.USD","LU1066051225.USD","LU1974910355.USD","BK4097","LU1629891620.HKD","ACWX","BLOX","LU2552382215.SGD","AVXC","LU1496350171.SGD","LU1868837722.USD","HK0000532082.HKD","BK4198","AVSE","IE00B775SV38.USD","SGXZ81514606.USD","LU0211327993.USD","LU0323240290.USD","LU0348723411.USD","IE00BSNM7G36.USD","ICOP","LU2089985449.USD","LU0316494557.USD","BK4527","LU0029864427.USD","LU0320765489.SGD","SG9999004220.SGD","LU2413666699.HKD","LU0612318385.USD","LU0889565833.HKD","IE00BYQQ9H92.USD","SPWO","USD","LU0444973449.USD","LU2637965513.SGD","TRFK","LU1839511570.USD","LU2097344431.USD","BK4007","LU1979441026.SGD","GB00BDT5M118.USD","IE00B4YYXB79.USD","LFGY","SOXY","LU1244550221.USD","LU1815333072.USD","BK4534","LU0345768740.USD","XNTK","IE0009356076.USD","LU0266512473.USD","LU0300736492.USD","KOMP","IE00BQXX3C00.GBP","LU0505663152.USD","LU0138981039.USD","LU0738911758.USD","IE00BDRTCR15.USD","LU1778281490.HKD","LU2361045086.USD","LU2100268510.USD","LU0070217475.USD","LU0187121727.USD","DOG","IE00BJTD4N35.SGD","LU0898699433.AUD","BK4512","CORO","FAI","LU0788109048.HKD","HK0000914686.HKD","LU1868836914.USD","ROM","BK4610","LU2237443622.USD","LU0949170772.SGD","AGOX","LU0661504455.SGD","LU0211328371.USD","LU0264606111.USD","LU1400636491.USD","LU1935042488.USD","LU2954938101.SGD","SNPE","RULE","IE00B3S45H60.SGD","BK4535","LU1323610961.USD","LU0096362180.USD","LU0985320562.USD","LU0072462426.USD","LU0081259029.USD","LU2756315664.SGD","EFIV","LU0143863198.USD","LU2417539215.USD","EART","LU2244417387.USD","IE00B4JS1V06.HKD","LU2211815571.USD","LU2249611893.SGD","LU1989772840.SGD","BK4553","LU1023057109.AUD","SG9999014880.SGD","SGXZ99366536.SGD","LU1267930813.SGD","LU0345768153.USD","BK4551","IE000M9KFDE8.USD","LU0329931173.USD","LU0109391861.USD","BK4543","AVEM","LU0965509283.SGD","LU2999663052.SGD","LU0345780950.USD","LU0787776722.HKD","BK4124","LU1066053197.SGD","SG9999014567.USD","JGRO","IE000YTNTUN2.SGD","FDTX","LU1989764664.SGD","LU1935043452.HKD","LU2506951792.HKD","LU0170899867.USD","LU0143551892.USD","LU1861127337.USD","LU2125909916.SGD","LU2430703095.HKD","LU1003077747.HKD","LU2746668461.USD","ESUM","BK4526","LU0359202008.SGD","BK4548","IE0004086264.USD","LU1084165304.USD","IE00BQXX3D17.EUR","LU1116320737.USD","LU0225283273.USD","LU2237443549.SGD","LU2092627202.USD","LU0210533765.USD","LU2505996681.GBP","LU0077335932.USD","LU1712237335.SGD","LU0511384066.AUD","LU2133065610.SGD","LU2420271590.USD","IE00BK4W5M84.HKD","LU0011850046.USD","LU1069344957.HKD","MEDX","LU0708995401.HKD","IE0034235188.USD","LU2360108059.USD","IE00BJJMRX11.SGD","LU1923622614.USD","IE00BJJMRZ35.SGD","LU0265550359.USD","LU0329931090.USD","LU2279689827.SGD","IETC","LU0823413660.USD","IE00B1XK9C88.USD","LU1951200564.SGD","LU1917777945.USD","ADVE","IE00B2B36J28.USD","IE000KEQY171.SGD","IE00BFSS8Q28.SGD","LU1282649067.USD","LU1064131342.USD","BK4575","LU2097344357.USD","LU0823413587.USD","IE00B19Z8W00.USD","LU0654597011.USD","SGXZ51526630.SGD","LU0788109121.HKD","LU0320765059.SGD","DXD","BK4578","LU0957791311.USD","LU2102340556.USD","BK4550","EDZ","LU0878005551.USD","LU0868494708.USD","BK4141","LU0791590937.USD","09388","LU2430703178.SGD","LU2054465674.USD","LU2347655156.SGD","LU0724617625.USD","SOXQ","BK4598","BK4579","BK4008","IE0004445239.USD","SG9999015358.SGD","HK0000819398.USD","LU0719512351.SGD","FMTL","LU0124676726.USD","LU2473716301.USD","IE000Q6AESB8.SGD","PBJ","EGGY","LU0203201768.USD","DGT","LU2125909759.SGD","LU2264538146.SGD","LU0359201885.HKD","LU2168563687.JPY","LU0057025933.USD","LU0080751232.USD","LU0075056555.USD","UDOW","LU1623119135.USD","SG9999000418.SGD","AIS","IE00BJLML261.HKD","LU2191332357.HKD","LU0820561909.HKD","LU0795875086.SGD","CHPX","LU1956131251.USD","LU0823431647.USD","LU2756315318.SGD","HK0000320223.HKD","LU1670756490.USD","LU0390134368.USD","LU2250418816.HKD","LU0417517546.SGD","LU0528227936.USD","CNEQ","LU0353189680.USD","159571","LU0300736062.USD","BK4077","LU0494093205.USD","LU0965509101.SGD","LU2023250330.USD","LU0132412106.USD","IE00BDCRKT87.USD","LU2048586759.USD","LU2063271972.USD","IE00BFXG0V08.USD","LU1508157978.USD","LU2272731782.SGD","BK4103","BK4588","LU1316542783.SGD","LU0157215616.USD","LU2087625088.SGD","LU0820562030.AUD","LU0823421333.USD","LU2083900584.USD","LU2326559502.SGD","LU0488056044.USD","LU0006306889.USD","LU1023059493.AUD","LU1069347547.HKD","LU2168564222.USD","LU2347655073.USD","LU0208291251.USD","LU1868837300.USD","ESIM","LU0210528500.USD","LU0545039389.USD","LU2896262040.SGD","LU2663582299.SGD","XLK","LU0133085943.USD","LU0942090050.USD","LU0964807845.USD","TRUM","IE00B19Z3B42.SGD","LU1821325948.USD","BK4591","LU1035775433.USD","BK4549","LU0823397103.USD","SG9999004303.SGD","LU0456854461.SGD","LU0531971165.HKD","SG9999014898.SGD","LU2028103732.USD","LU0310799852.SGD","LU0048584097.USD","IE00BWXC8680.SGD","LU0215105999.USD","LU1244550577.SGD","LU1366192091.USD","LU1934455863.HKD","LU0345770993.USD","IE00B3M56506.USD","LU1989764748.USD","LU2360107168.USD","SGXZ31699556.SGD","SG9999002521.SGD","LU2592432038.USD","PPH","THMR","LU1119994496.HKD","LU2047632596.USD","LU2247934214.USD","LU1732800096.USD","LU1868836591.USD","IE00B5TLWC47.USD","LU1261432733.SGD","IE00BJTD4V19.USD","03145","TTEQ","LU2505996509.AUD","SG9999015945.SGD","LU2265009873.SGD","LU0689472784.USD","LU2471134952.CNY","LU1951198990.SGD","LU2456880835.USD","LU1642822529.SGD","LU2394011477.USD","UMMA","TTXU","LU0342679015.USD","LU2462591350.SGD","IE00BFSS7M15.SGD","NULC","LU1880398554.USD","IE00BJT1NW94.SGD","BK4592","LU0323239441.USD","LU0820561818.USD","LU0347712357.USD","LU0823397285.USD","LU0354030511.USD","LU0672654240.SGD","LU0630314457.HKD","LU2065170008.USD","IE00B775H168.HKD","LU0878004406.USD","SG9999014542.SGD","LU2242649171.HKD","LU0791591158.USD","IE0034235303.USD","TEK","LU0251132253.USD","LU1868837136.USD","SG9999017495.SGD","LU1400636574.HKD","SPTE","LU0198837287.USD","LU2087621335.USD","IE00BZ1G4Q59.USD","BK4614","LU1571399168.USD","BK4503","WISE","LU0612318971.USD","IE0009G5SDU7.USD","LU0689626769.HKD","LU1814569148.SGD","HK0000914660.USD","LU0276348264.USD","LU2286300806.USD","LU2237443978.SGD","BK4023","09788","FTXL","BOBP","BK4188","LU2237443465.HKD","IE0002141913.USD","LU1429558221.USD","IE0004091025.USD","LU2125154935.USD","BK7094","IE00B3SWFQ91.USD","LU0823434583.USD","LU1430597077.USD","LU0912757837.SGD","LU2403377893.USD","IE0005OL40V9.USD","LU1127390331.HKD","PTF","LU0174119429.USD","LU1366334578.USD","LU2750360641.GBP","LU0061475181.USD","LU2471134523.USD","IE00BYXW3230.USD","LU0210536198.USD","LU2237957811.SGD","LU3102509885.SGD","DINT","ABFL","CGGO","SG9999015978.USD","LU2272731600.USD","LU0143863784.USD","LU0572939691.SGD","LU1815336760.USD","BK4554","HBMX","IE00BFTCPJ56.SGD","LU1791710400.SGD","LU0070302665.USD","SMH","LU0572108347.SGD","LU1935043023.USD","LU1861220033.SGD","LU2125154778.USD","HK0000304797.USD","DIA","LU0310800379.SGD","BK4529","LU0395794307.EUR","LU2361044949.HKD","LU2242650005.HKD","AIPI","LU2236285917.USD","DRMY","SG9999014914.USD","IE00BKVL7J92.USD","LU1861559042.SGD","LU0882574139.USD","LU2471134879.HKD","IE00BN29S564.USD","LU1804176565.USD","LU0823431563.USD","LU0289960550.SGD","LU1992135472.HKD","LU1983260115.SGD","VGT","BK4505","LU0795875169.SGD","LU2237957902.USD","LU1037948897.HKD","LU1435385759.SGD","BK4500","LU0640476718.USD","CHAT","LU1211504680.USD","IE0001KFT4U8.USD","LU0267386448.USD","LU1267930730.SGD","LU0154236417.USD","LU1815336091.USD","LU0234572021.USD","IE00BHPRN162.USD","LU0061474960.USD","LU1066051498.USD","LU1496350502.SGD","LU1267930573.SGD","LU0158827948.USD","USXF","IE00BKDWB100.SGD","LU1732799900.SGD","CGNG","LU2462591277.SGD","LU2491049909.HKD","TINS","LU2860962120.EUR","WUGI","LU0109392836.USD","LU0256863811.USD","LU1868837565.USD","LU1718418525.SGD","LU1267930490.SGD","KNOW","LU0069063385.USD","LU0234570918.USD","LU1861558580.USD","LU1244550494.USD","LU1935042991.SGD","BK4209","LU0079474960.USD","LU2413666426.HKD","LU0708994859.HKD","LU0203347892.USD","IE00B19Z3581.USD","SG9999014575.USD","LU2271345857.HKD","LU0359201612.USD","BK4566","IE00B7KXQ091.USD","BK4015","IXN","LU0345769631.USD","LU0345770308.USD","LU1699723380.USD","IE00BK4W5L77.USD","LU2430703251.USD","LU0203345920.USD","MEMX","LU0979878070.USD","CMAG","SGXZ80539844.SGD","LU1232071149.USD","XTN","BK4585","LU1559883803.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666622025","title":"諾華製藥(NVS.US)大股東呼籲改組董事會，以改善公司治理。此前該公司股價因連續試驗受挫於本周創下紀錄跌幅。大股東Da","url":"https://stock-news.laohu8.com/highlight/detail?id=2666622025","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666622025?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 18:25","pubTimestamp":1789035953,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","IE0009355771.USD","SYLD","LU0208291251.USD","IE00B2B36J28.USD","BK4578","IE00BJJMRZ35.SGD","WCEO","LU0070302665.USD","MEDX","IE0002141913.USD","BK4007","NVS","BK4532","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","LU0211331839.USD","BK4588","PPH","IE00BFTCPJ56.SGD","LU0320765489.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666562462","title":"Artisan Partners：在藥物試驗接連受挫後 諾華應在董事會層面進行改組","url":"https://stock-news.laohu8.com/highlight/detail?id=2666562462","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666562462?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 18:23","pubTimestamp":1789035834,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0070302665.USD","LU0320765489.SGD","LU0211331839.USD","IE0009355771.USD","IE00B4R5TH58.HKD","IE00B2B36J28.USD","NVS","LU0208291251.USD","BK4585","BK4532","IE00BJT1NW94.SGD","BK4588","PPH","IE0002141913.USD","BK4007","BK4578","IE00BJJMRZ35.SGD","MEDX","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666553725","title":"滙豐：將諾華製藥的評級上調至「持有」，目標價110瑞士法郎。","url":"https://stock-news.laohu8.com/highlight/detail?id=2666553725","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666553725?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 07:44","pubTimestamp":1788997467,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4007","IE0002141913.USD","BK4578","IE00BJT1NW94.SGD","MEDX","LU0208291251.USD","LU0320765489.SGD","IE00BFTCPJ56.SGD","NVS","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","PPH","BK4532","LU0211331839.USD","BK4588","BK4585","IE00B4R5TH58.HKD","IE0009355771.USD","FXF","LU0070302665.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666531862","title":"心血管新藥研發遇困局：諾華重磅臨床折戟 Lp（a）指標降了但心血管疾病風險沒降","url":"https://stock-news.laohu8.com/highlight/detail?id=2666531862","media":"每日经济新闻","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666531862?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 22:52","pubTimestamp":1788965533,"startTime":"0","endTime":"0","summary":"9月4日，诺华与Ionis合作开发的Lp（a）〔即：脂蛋白（a）——编者注〕靶向药物pelacarsen的Lp（a）HORIZONⅢ期临床试验公布结果。这款被行业寄予厚望的候选药物，虽能大幅降低Lp（a）水平，却未能显著降低心血管事件风险，给全球心血管创新药赛道投下了一片不确定性阴影。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609093869631090.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609093869631090.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","BK4588","LU0320765489.SGD","MEDX","IE00BJT1NW94.SGD","BK4585","IE00B2B36J28.USD","BK4578","LU0208291251.USD","BK4007","LU0070302665.USD","BK4532","NVS","LU0211331839.USD","PPH","IE0009355771.USD","IE0002141913.USD","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666308479","title":"我武生物董事長因個人原因辭職；諾華新藥III期臨床未達主要終點 | 醫藥早參","url":"https://stock-news.laohu8.com/highlight/detail?id=2666308479","media":"每日经济新闻","labels":["executive","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666308479?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 07:01","pubTimestamp":1788908468,"startTime":"0","endTime":"0","summary":"丨2026年9月9日星期三丨NO.1诺华制药DM1药物III期临床未达主要终点9月8日，诺华制药宣布，其评估del-desiran治疗1型强直性肌营养不良（DM1）的III期HARBOR研究未达到主要终点。公司表示，将进一步分析完整数据，并与监管机构沟通后确定后续开发路径。点评：消息放出后，诺华股价明显受挫，反映资本市场对该管线预期大幅下调。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609093868484469.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609093868484469.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0320765489.SGD","IE00B2B36J28.USD","159938","BK0239","BK4007","BK4532","LU0208291251.USD","IE00BFTCPJ56.SGD","BK1161","IE0002141913.USD","BK1574","BK4588","NVS","BK1515","MEDX","IE00BJJMRZ35.SGD","LU0211331839.USD","PPH","BK4578","BK0028","LU0070302665.USD","IE00BJT1NW94.SGD","09939","300357","IE0009355771.USD","BK4585","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136308873","title":"Assembly Biosciences有望獲得高達2.8億美元里程碑付款及美國境外特許權使用費","url":"https://stock-news.laohu8.com/highlight/detail?id=1136308873","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136308873?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 04:02","pubTimestamp":1788897732,"startTime":"0","endTime":"0","summary":"Assembly Biosciences公司日前披露，其在海外市场具备资格获取最高达2.8亿美元的里程碑款项，外加相应特许权使用费收入。据悉，这家生物科技企业所预期的资金流入将源自美国以外地区。对Assembly Biosciences而言，这笔潜在收入不仅反映其管线资产的外部合作价值，也可能为其后续研发投入提供坚实支撑。市场人士认为，此类非美国市场的收益结构有助于分散地域风险，增强公司财务韧性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIB","LU1934455194.USD","TMED","LU2087621335.USD","LU1430594728.SGD","LU1778281490.HKD","LU0882574055.USD","LU0965509101.SGD","BK4583","IE00BZ1G4Q59.USD","LU1037948897.HKD","TBXU","IE0002270589.USD","IE00B3T34201.USD","LU0861579265.USD","LU0114720955.EUR","BK4139","IBBQ","LU0823416689.USD","LU0965509010.AUD","LU1066051498.USD","LU2089984988.USD","LU2357627491.SGD","LU0889565916.HKD","LU1674673428.USD","LU0859254822.USD","LU0289739699.SGD","LU0965508806.USD","LU1061106388.HKD","LU1674673691.USD","LU1934455277.USD","LU1839511570.USD","LU1023059063.AUD","BK4585","LU1571399168.USD","BK4578","LU1934455863.HKD","IE00BSNM7G36.USD","LU2324357040.USD","IE00B19Z3B42.SGD","LU0965509283.SGD","IE00B19Z3581.USD","BK4532","IE00BKVL7J92.USD","BK4566","LU1037948541.HKD","SG9999015945.SGD","BBH","LU0320765992.SGD","LU2112291526.USD","BK4568","LU1066053197.SGD","IE00B7SZLL34.SGD","LU0234570918.USD","SG9999015986.USD","LU1057294990.SGD","LU1585245621.USD","LU2468319806.SGD","LU0058720904.USD","LU0122379950.USD","MEDI","BK4588","GILD","BMED","BK4550","IBB","SG9999015952.SGD","SG9999015978.USD","ASMB","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154623157","title":"Assembly Biosciences旗下Gs-1179預計2026年底前將推進至生殖器皰疹二期臨床試驗階段","url":"https://stock-news.laohu8.com/highlight/detail?id=1154623157","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154623157?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 04:02","pubTimestamp":1788897731,"startTime":"0","endTime":"0","summary":"Assembly Biosciences公司日前宣布，其研发管线中的候选药物Gs-1179有望在2026年年底之前顺利迈入针对生殖器疱疹的二期临床试验阶段。生殖器疱疹作为一种常见的性传播感染疾病，全球患者群体庞大，对创新疗法的需求十分迫切。Assembly Biosciences正积极加速该药物的研发进程，以期尽早为患者带来新的治疗选择。业内分析人士指出，若Gs-1179能够顺利通过后续试验的严格考验，将可能重塑该适应症的市场格局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3581.USD","LU0965509101.SGD","LU0234570918.USD","LU0823416689.USD","LU2468319806.SGD","ASMB","BK4532","LU1066053197.SGD","BK4568","LU0289739699.SGD","LU0859254822.USD","SG9999015952.SGD","LU1934455194.USD","LU0889565916.HKD","LU1037948541.HKD","LU0965508806.USD","TMED","LU1057294990.SGD","LU0965509283.SGD","LU1934455863.HKD","LU2089984988.USD","SG9999015945.SGD","LU1674673428.USD","LU0114720955.EUR","BIB","LU1778281490.HKD","BK4588","IE00B7SZLL34.SGD","BK4550","LU2087621335.USD","IE00BZ1G4Q59.USD","LU2112291526.USD","LU1674673691.USD","LU1061106388.HKD","BK4566","IE00B19Z3B42.SGD","LU0320765992.SGD","LU1934455277.USD","LU0058720904.USD","LU1571399168.USD","LU0861579265.USD","LU1585245621.USD","IE00B3T34201.USD","IBB","IE00BSNM7G36.USD","MEDI","LU2324357040.USD","BK4578","SG9999015978.USD","IBBQ","LU0965509010.AUD","BBH","TBXU","IE00BKVL7J92.USD","LU0882574055.USD","LU1430594728.SGD","BK4139","LU1023059063.AUD","LU1839511570.USD","BMED","LU0109394709.USD","LU0122379950.USD","IE0002270589.USD","SG9999015986.USD","BK4583","GILD","BK4585","LU1066051498.USD","LU2357627491.SGD","LU1037948897.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115029168","title":"Assembly Biosciences：吉利德獨享HSV HPI項目臨床開發與商業化權利","url":"https://stock-news.laohu8.com/highlight/detail?id=1115029168","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115029168?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 04:01","pubTimestamp":1788897702,"startTime":"0","endTime":"0","summary":"Assembly Biosciences宣布，吉利德科学已保留其HSV HPI项目的独家临床开发及商业化权利。这一决定标志着双方合作进一步深化，吉利德将全权主导该项目的后续推进与市场布局。对于Assembly Biosciences而言，此举不仅明确了合作伙伴的战略优先级，也为其自身聚焦其他管线资源提供了更大灵活性。业内观察人士指出，HSV HPI项目的独家授权，反映了吉利德在抗病毒治疗领域持续加码的雄心，同时也凸显了该类创新疗法在未被满足的医疗需求中所蕴含的巨大潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0114720955.EUR","SG9999015945.SGD","LU0289739699.SGD","LU1061106388.HKD","TBXU","MEDI","IE00BKVL7J92.USD","IE00BSNM7G36.USD","LU1934455277.USD","IE00B19Z3581.USD","LU0889565916.HKD","LU0965509283.SGD","LU0859254822.USD","LU1571399168.USD","LU1674673428.USD","LU2089984988.USD","LU0122379950.USD","LU2468319806.SGD","LU0965509010.AUD","BK4578","LU1057294990.SGD","LU1430594728.SGD","LU1066053197.SGD","GILD","LU1585245621.USD","BIB","BK4550","BK4532","BMED","LU1778281490.HKD","LU0234570918.USD","LU1066051498.USD","LU1023059063.AUD","LU0965508806.USD","BK4568","BK4588","LU1674673691.USD","IE00B7SZLL34.SGD","IE00B3T34201.USD","LU0882574055.USD","LU1037948541.HKD","IBBQ","LU0965509101.SGD","LU0058720904.USD","BBH","SG9999015986.USD","ASMB","IBB","IE00B19Z3B42.SGD","IE0002270589.USD","LU0109394709.USD","LU0823416689.USD","BK4139","LU2357627491.SGD","LU0320765992.SGD","IE00BZ1G4Q59.USD","SG9999015978.USD","TMED","LU1037948897.HKD","LU1934455863.HKD","SG9999015952.SGD","BK4583","LU2324357040.USD","BK4566","LU1839511570.USD","LU0861579265.USD","LU1934455194.USD","BK4585","LU2112291526.USD","LU2087621335.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179230759","title":"Assembly Biosciences行使與吉利德關於HSV解旋酶-引物酶抑制劑項目的美國利潤分成選擇權","url":"https://stock-news.laohu8.com/highlight/detail?id=1179230759","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179230759?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 04:01","pubTimestamp":1788897669,"startTime":"0","endTime":"0","summary":"Assembly Biosciences公司已正式行使与吉利德科学就HSV解旋酶-引物酶抑制剂项目达成的美国利润分成选择权。这一战略举措标志着双方合作进入新阶段，有望加速该抗病毒疗法的临床开发与商业化进程。通过行使该选择权，Assembly Biosciences将能够分享该药物在美国市场的未来收益，同时借助吉利德在抗病毒领域的深厚积累与市场渠道，共同推进这一潜在重磅药物的落地。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3581.USD","LU1934455863.HKD","BK4566","BK4578","LU1066053197.SGD","LU1585245621.USD","IE00B3T34201.USD","IE00B19Z3B42.SGD","LU0122379950.USD","LU0320765992.SGD","BK4550","LU1674673691.USD","LU0861579265.USD","LU0882574055.USD","BK4532","IE00BSNM7G36.USD","LU1037948541.HKD","LU1037948897.HKD","LU1061106388.HKD","LU0114720955.EUR","BK4588","LU1430594728.SGD","TMED","LU2324357040.USD","SG9999015945.SGD","SG9999015986.USD","LU2357627491.SGD","IBBQ","LU0289739699.SGD","BIB","LU0058720904.USD","LU0109394709.USD","MEDI","ASMB","LU0965508806.USD","LU2112291526.USD","SG9999015952.SGD","BK4139","IE0002270589.USD","BK4568","SG9999015978.USD","BK4583","IE00BZ1G4Q59.USD","LU1778281490.HKD","IE00BKVL7J92.USD","LU0965509283.SGD","LU1934455194.USD","LU2087621335.USD","LU2089984988.USD","LU2468319806.SGD","LU1066051498.USD","IBB","LU0823416689.USD","LU1057294990.SGD","LU0965509101.SGD","BBH","LU1674673428.USD","IE00B7SZLL34.SGD","BK4585","LU0859254822.USD","LU1571399168.USD","LU1934455277.USD","LU0889565916.HKD","BMED","LU0234570918.USD","TBXU","GILD","LU0965509010.AUD","LU1839511570.USD","LU1023059063.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666374570","title":"吉利德科學(GILD)股票9月8日盤中下跌3.26%：釋放什麼信號？","url":"https://stock-news.laohu8.com/highlight/detail?id=2666374570","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666374570?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 01:16","pubTimestamp":1788887780,"startTime":"0","endTime":"0","summary":"• 吉利德在经历了长达数月的持续上涨后，因获利回吐而出现回调。\n• 强劲的第二季度营收主要受其旗舰 HIV 和 Trodelvy 产品线的推动。\n• 分析师维持“买入”评级，平均目标价为 157.79 美元。","market":"other","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262156554-market-movers-gild-20260908","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","LU0058720904.USD","IE00BKVL7J92.USD","LU0965509101.SGD","LU2324357040.USD","LU0114720955.EUR","IBB","LU0289739699.SGD","TBXU","IBBQ","BBH","IE00BSNM7G36.USD","LU1839511570.USD","BK4578","LU1674673691.USD","LU1674673428.USD","LU0823416689.USD","LU1571399168.USD","SG9999015952.SGD","IE00B7SZLL34.SGD","MEDI","IE00BZ1G4Q59.USD","SG9999015945.SGD","BMED","GILD","IE0002270589.USD","LU1778281490.HKD","LU1934455277.USD","LU2112291526.USD","IE00B3T34201.USD","TMED","BK4583","IE00B19Z3581.USD","LU0109394709.USD","LU2087621335.USD","LU1430594728.SGD","BIB","LU0122379950.USD","BK4568","LU0861579265.USD","LU1023059063.AUD","LU1037948541.HKD","BK4585","SG9999015978.USD","SG9999015986.USD","LU0965508806.USD","BK4532","IE00B19Z3B42.SGD","LU0859254822.USD","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665750913","title":"美股異動｜諾華製藥重挫超13%創1月以來新低，三項臨床項目接連受挫","url":"https://stock-news.laohu8.com/highlight/detail?id=2665750913","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665750913?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 22:00","pubTimestamp":1788876050,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0211331839.USD","MEDX","IE00BJT1NW94.SGD","IE00B2B36J28.USD","NVS","LU0320765489.SGD","LU0208291251.USD","BK4578","IE00BFTCPJ56.SGD","BK4007","BK4532","PPH","LU0070302665.USD","BK4588","IE00BJJMRZ35.SGD","IE0002141913.USD","IE00B4R5TH58.HKD","IE0009355771.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":57,"code":"91000000","status":"200"}]}}